This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Whitehead Institute for Biomedical Research, The General Hospital Corporation. Active years: 2020-2024.
Company Filing History:
3 out of 317 
2 out of 3,070 
Years Active: 2020-2024
Title: The Innovative Contributions of Mohammad Rashidian
Introduction
Mohammad Rashidian is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel methods for antibody labeling and protein radiolabeling. With a total of 3 patents to his name, Rashidian's work has the potential to impact diagnostic and therapeutic applications in medicine.
Latest Patents
Rashidian's latest patents include innovative methods for the labeling of antibodies. These methods provide site-specific PEG modifications to single domain antibodies, such as VHHs. Additionally, he has developed techniques for producing site-specifically conjugated bivalent single domain antibodies. His work also encompasses methods for labeling these antibodies with fluorophores or radionuclides. Another notable patent involves the 18F labeling of proteins using sortases. This invention offers methods, reagents, and kits for the radiolabeling of proteins, which are essential for positron emission tomography (PET) and single-photon emission computed tomography (SPECT). These advancements are crucial for both diagnostic and therapeutic applications.
Career Highlights
Throughout his career, Rashidian has worked with esteemed institutions, including the Whitehead Institute for Biomedical Research and the General Hospital Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of biomedicine.
Collaborations
Rashidian has collaborated with notable figures in the field, including Hidde L Ploegh and Ralph Weissleder. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
In summary, Mohammad Rashidian is a distinguished inventor whose work in antibody and protein labeling has the potential to revolutionize medical diagnostics and therapies. His contributions are a testament to the importance of innovation in the biomedical field.